HUSSMAN STRATEGIC ADVISORS, INC.
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1179475
ELLICOTT CITY, MD
Position in KNSA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,011,150
-$1,088,010 QoQ
Shares Held
21,000
-75.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $14,844,480 across 6 Drug Manufacturers - Specialty & Generic names. KNSA ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
52,500 | $4,037,250 | |
| 2 | COLL |
Collegium Pharmaceutical, Inc
|
105,000 | $3,472,350 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
21,000 | $2,766,540 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
42,000 | $2,323,020 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
63,000 | $1,234,170 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
21,000 | $1,011,150 |
All Filings in KNSA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,011,150 | 21,000 | Shares | Sole | 2026-05-11 | |
| 2024-09-30 | $2,099,160 | 84,000 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,744,490 | 147,000 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||